What: BMJ publishes a personal account detailing the emotional and practical challenges of being labeled high risk during pregnancy.
Key line: “I was condemned to feel shame…”
Source: BMJ.
A study highlights an increased risk of preterm birth and low birthweight for individuals infected with COVID-19 during pregnancy.
Texas Democrats push for maternal mortality transparency and tracking.
A deep dive on the ethical implications of working with human embryos.
A University of Oklahoma study found that waiting more than 42 days for certain breast cancer surgeries increased mortality risk.
NIH announced winners of a competition focused on endometriosis diagnostics using menstrual blood and specialized imaging.
RFK Jr. plans to cut 10,000 jobs, causing concerns over public health.
Research compares telehealth patients seeking abortion pills for future use to those seeking them for current pregnancies.
WalletHub ranks the best and worst states for women, factoring in health metrics.
Studies reinforce that HRT timing may affect Alzheimer’s risk.
Abortion bans reduce OBGYN care access in restrictive states.
FDA ends approval for compound versions of GLP-1 weight loss drugs.
Context reports on the censorship faced by women’s health companies from Big Tech, with many ads rejected or content taken down.
Increased daily steps reduce cardiovascular risk for postmenopausal women.
A randomized trial showed virtual education and follow-up via WhatsApp lowered postpartum depression rates.
Marty Makary faces controversies as the new FDA commissioner.
Carolina Public Press highlights potential solutions to the maternal care crisis in rural areas of North Carolina.
AI can analyze breast artery calcifications in mammograms to assess cardiovascular risk.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
Maternal deaths due to cardiovascular issues more than doubled in the US between 1999 and 2022, with Black women and people in Southern states facing increased risk.
A study of over 350,000 pregnancies found that 11% of women used cannabis before conception, and 6% used it during pregnancy, likely to manage nausea.